AbbVie Announces Public Voting Open for 30th Annual Cystic Fibrosis Thriving Student Awards

  • Online and mobile voting is now open to the public via September 28 to help determine this year’s two Thriving Scholars
  • Forty students living with cystic fibrosis (CF) are in the running for both $25,000 awards based on academic excellence, creativity, and community involvement/extracurricular activities
  • This year’s scholarship program brands 30 years of AbbVie’s commitment to students with cystic fibrosis pursuing graduate studies


NORTH CHICAGO, Illinois., September 14, 2022 /PRNewswire/ — AbbVie today announced the start of its two-week public voting period for the 2022 Thriving Undergraduate and Graduate Scholarships. Following this voting period, scholarships totaling $25,000 each will be awarded to two commendable students with cystic fibrosis (CF), a chronic, inherited disease that affects the lungs and digestive system.


From today until September 28 at 10:00 a.m. Central Time, the public is encouraged to visit the official AbbVie CF Scholarship website (www.AbbVieCFScholarship.com) to learn more about this year’s top 40 scholars through their essays and creative presentations. The public can then vote to help select the 2022 Undergraduate and Graduate Scholarship recipients. the two-week public voting period.


“In addition to being a recipient of the AbbVie CF Fellowship, I am grateful that I was able to share my cystic fibrosis story with the world,” said Melissa W., 2021 Thriving Graduate Student. “As I pursue my studies in human resource management on this scholarship, I am excited to continue using my voice to inspire and advocate for others.”


Earlier this year, AbbVie selected 40 undergraduate and graduate students living with CF as recipients of a $3,000 scholarship to be used during the 2022-2023 academic year. The award was based on their academic excellence, creativity and involvement in the community/extracurricular activities. These 40 students now have the opportunity to obtain the title of “Prosperous Undergraduate or Graduate Student 2022” and another $22,000 in the financing of scholarships for their higher education. The two winners will be determined by the number of valid votes cast by the public and the cumulative points awarded to each scholar by AbbVie’s judging panel who evaluated the students’ essays and creative presentations.


“The 30e anniversary of the AbbVie CF Scholarship Program commemorates the community of students we have been able to support over the years in their efforts to pursue higher education,” said John Duffey, Vice President, US Specialty, AbbVie. “The Top 40 recipients of 2022 are beyond deserving and have impressed us all with their inspiring stories and ambitions to pursue their goals while living with CF.


AbbVie will announce the 2022 thriving undergraduate and graduate students in early November.


About Cystic Fibrosis
Cystic fibrosis (CF) is a chronic, inherited disease that affects the lungs, pancreas, and other organs of people with this disease.1 In patients with cystic fibrosis, thick, sticky mucus is produced in certain organs of the body, most commonly the lungs and the digestive system. Mucus buildup in the lungs can lead to difficulty breathing and lead to life-threatening lung infections. In the pancreas, thick mucus can prevent the release of digestive enzymes and proper digestion of food, which can lead to malabsorption and malnutrition.


About AbbVie CF Scholarship
The AbbVie CF Scholarship was established 30 years ago in recognition of the financial burdens faced by many families affected by CF and to recognize the achievements of students with CF. Since its inception, the scholarship program has awarded more than $3.7 million in scholarships to more than 1,000 students. The AbbVie CF Scholarship is part of AbbVie’s ongoing commitment to the CF community, which includes more than 30,000 people in United States. Today, more than half of the CF population is 18 years of age or older.1


Fellowship applicants do not need to have taken, are currently taking, or intend to take in the future any drug or product marketed by AbbVie, and this is not considered in the eligibility criteria. selection. More information on the AbbVie CF scholarship criteria and application can be found at www.AbbVieCFScholarship.com.


About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve the serious health problems of today and meet the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives in several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition products and services from its Allergan Aesthetics portfolio. For more information about AbbVie, visit www.abbvie.com. Follow @abbvie on TwitterFacebook, LinkedIn or Instagram.




View original content: https://www.prnewswire.com/news-releases/abbvie-announces-public-voting-open-for-30th-annual-cystic-fibrosis-scholarship-thriving-student-awards-301624465.html


SOURCEAbbVie

Comments are closed.